Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMC 1493795)

Published in Ann Surg on November 01, 1988

Authors

T Leese1, O Farges, H Bismuth

Author Affiliations

1: Hepatobiliary Unit, Hôpital Paul Brousse, Villejuif, France.

Articles citing this

Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) (2005) 1.56

Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) (2010) 1.51

Laparoscopic liver resections: a single center experience. Surg Endosc (2005) 1.33

Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg (2000) 1.22

Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. World J Gastroenterol (2005) 1.06

The value of laparoscopic liver surgery for solid benign hepatic tumors. Surg Endosc (2007) 1.03

Hepatic adenomas in male patients. HPB (Oxford) (2004) 0.96

Distinguishing benign from malignant liver tumours. Cancer Imaging (2007) 0.95

Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB (Oxford) (2012) 0.93

Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions. World J Radiol (2009) 0.92

Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy. Korean J Radiol (2009) 0.87

Surgical management of spontaneous ruptured hepatocellular adenoma. Clinics (Sao Paulo) (2009) 0.87

Has laparoscopy increased surgical indications for benign tumors of the liver? Langenbecks Arch Surg (2012) 0.87

Molecular pathogenesis of hepatic adenomas and its implications for surgical management. J Gastrointest Surg (2013) 0.86

Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year single-centre experience. HPB (Oxford) (2012) 0.84

Necrosis of a large hepatic tumor after hemorrhage and subsequent selective arterial embolization. World J Gastroenterol (2006) 0.84

Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. HPB (Oxford) (2014) 0.82

Laparoscopic liver resection for hepatocellular adenoma. World J Gastrointest Surg (2011) 0.82

Liver cell adenoma: a case report with clonal analysis and literature review. World J Gastroenterol (2006) 0.81

A case of hepatocellular carcinoma within hepatocellular adenoma in a non-cirrhotic male. Korean J Intern Med (2009) 0.81

The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Eur Radiol (2014) 0.81

Benign Neoplasms of the Liver. Curr Treat Options Gastroenterol (2001) 0.80

PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. HPB (Oxford) (2015) 0.80

Malignant transformation of hepatic adenoma with recurrence after resection. HPB (Oxford) (2002) 0.78

[Hepatocellular adenoma. Malignancy potential and differentiation from hepatocellular carcinoma]. Pathologe (2006) 0.77

Benign liver tumors in pediatric patients - Review with emphasis on imaging features. World J Gastroenterol (2015) 0.77

Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma. World J Gastroenterol (2009) 0.75

Malignant transformation of hepatocellular adenoma: how frequently does it happen? Liver Cancer (2015) 0.75

Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol (2016) 0.75

Exuberant liver adenomatosis presenting with iron deficiency anemia. Clin Case Rep (2017) 0.75

Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization. Hepatol Int (2009) 0.75

Hepatic adenomatosis: a rare but important liver disease with severe clinical implications. Int Surg (2015) 0.75

Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers. Chin J Cancer (2015) 0.75

Synchronous giant hepatic adenoma in siblings-A case report and brief literature review. Cancer Biol Ther (2016) 0.75

Synchronous bleeding of liver adenomatosis and possible relation to acoustic trauma. HPB (Oxford) (2001) 0.75

Rupture of a hepatic adenoma in a young woman after an abdominal trauma: a case report. World J Gastroenterol (2013) 0.75

Large hepatic adenoma in a 21-year-old male. BMJ Case Rep (2013) 0.75

A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Eur Radiol (2017) 0.75

Articles cited by this

Possible association between benign hepatomas and oral contraceptives. Lancet (1973) 3.98

Surgical anatomy and anatomical surgery of the liver. World J Surg (1982) 3.96

Experience with 150 liver resections. Ann Surg (1983) 3.01

Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology (1977) 1.82

Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology (1983) 1.76

The use of operative ultrasound in surgery of primary liver tumors. World J Surg (1987) 1.64

Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology (1985) 1.62

Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med (1977) 1.50

Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancet (1980) 1.37

Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J (1975) 1.36

Resection of primary solid hepatic tumors. Am J Surg (1981) 1.34

Letter: Hepatomas and oral contraceptives. Lancet (1974) 1.32

Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Intern Med (1986) 1.31

Hepatic cell adenomas, spontaneous liver rupture, and oral contraceptives. Arch Surg (1975) 1.27

Liver transplantation for type I glycogen storage disease. Lancet (1983) 1.20

Liver resection for hepatic adenoma. Arch Surg (1979) 1.09

Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy. Gastroenterology (1981) 1.09

Androgen related primary hepatic tumors in non-Fanconi patients. Cancer (1983) 1.08

Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives. Arch Pathol Lab Med (1981) 1.05

Hepatic neoplasms associated with contraceptive and anabolic steroids. Recent Results Cancer Res (1979) 1.01

Hepatic adenomata with type 1 glycogen storage disease. JAMA (1976) 0.99

Experience with benign tumors of the liver. Surg Gynecol Obstet (1970) 0.99

Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci (1981) 0.99

Sex hormones and hepatic neoplasia. Cancer Res (1976) 0.95

Multiple tumors after androgen therapy. Arch Pathol Lab Med (1977) 0.94

Elective hepatic resection. Am J Surg (1979) 0.92

Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver. J Pediatr (1969) 0.92

Progressive enlargement of an hepatic cell adenoma. Gastroenterology (1979) 0.89

Spontaneous liver cell adenoma in children. Am J Clin Pathol (1986) 0.88

Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature. Surgery (1985) 0.88

Asymptomatic liver cell adenomas. Another case of resolution after discontinuation of oral contraceptive use. JAMA (1978) 0.86

Benign hepatocellular tumors. Surgery (1977) 0.85

Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years. Cancer (1977) 0.84

Benign hepatocellular tumours. Scand J Gastroenterol (1975) 0.83

Primary benign solid tumors of the liver. Am J Surg (1977) 0.83

Hepatic adenoma. Observations after estrogen withdrawal. Arch Surg (1976) 0.83

Hepatic-cell adenoma presenting with intraperitoneal haemorrhage in the puerperium. Br Med J (1977) 0.81

Proper management of hepatic adenoma associated with oral contraceptives. Surg Gynecol Obstet (1977) 0.80

Reasonable surgical treatment for tumors of the liver associated with the use of oral contraceptives. Surg Gynecol Obstet (1979) 0.79

Articles by these authors

(truncated to the top 100)

Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg (2000) 5.79

Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med (1993) 4.43

Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 4.17

Surgical anatomy and anatomical surgery of the liver. World J Surg (1982) 3.96

Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol (1999) 2.80

Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg (1999) 2.68

Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery (1984) 2.63

Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology (2000) 2.46

Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg (1991) 2.46

Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol (2001) 2.43

Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg (1997) 2.28

Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg (1988) 2.26

Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg (2000) 2.16

Liver resections in cirrhotic patients: a Western experience. World J Surg (1986) 2.05

Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg (2003) 2.04

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology (1995) 2.00

Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99

Repeat hepatectomy for colorectal liver metastases. Ann Surg (1997) 1.99

Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant (2010) 1.93

Long term results of Roux-en-Y hepaticojejunostomy. Surg Gynecol Obstet (1978) 1.85

Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med (1997) 1.83

Laparoscopy extends the indications for liver resection in patients with cirrhosis. Br J Surg (1999) 1.79

Partial portacaval shunt: renaissance of an old concept. Surgery (1992) 1.79

Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg (2010) 1.72

Cytolysis following chemoembolization for hepatocellular carcinoma. Br J Surg (1999) 1.70

Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68

Laparoscopic liver resection of benign liver tumors. Surg Endosc (2002) 1.68

Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet (1992) 1.68

Major and minor segmentectomies "réglées" in liver surgery. World J Surg (1982) 1.65

The use of operative ultrasound in surgery of primary liver tumors. World J Surg (1987) 1.64

Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology (1985) 1.62

Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol (2001) 1.61

Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg (2006) 1.57

Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56

Bronchobiliary fistulas in adults. Ann Surg (1988) 1.55

In situ split liver transplantation for two adult recipients. Transplantation (2000) 1.53

Gallbladder cancer: the polyp-cancer sequence. Br J Surg (1990) 1.50

Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol (1993) 1.49

Hematobilia resulting from heterotopic stomach in the gallbladder neck. Surgery (1989) 1.48

Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest (1992) 1.45

Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg (1974) 1.43

Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol (1999) 1.42

[Living donor in liver transplantation. Present and future alternatives]. Gastroenterol Clin Biol (2000) 1.40

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38

[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience]. Gastroenterol Clin Biol (2001) 1.38

The course of hepatitis C virus infection after liver transplantation. Hepatology (1994) 1.38

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology (1993) 1.36

Split-liver transplantation. The Paul Brousse policy. Ann Surg (1996) 1.35

Segmental liver resection using ultrasound-guided selective portal venous occlusion. Ann Surg (1989) 1.32

Output of chyle as an indicator of treatment for chylothorax complicating oesophagectomy. Br J Surg (1998) 1.32

Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg (1999) 1.31

Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg (1995) 1.30

Is there a role of preservation of the spleen in distal pancreatectomy? J Am Coll Surg (1999) 1.30

Liver transplantation across ABO blood group barriers. Lancet (1990) 1.29

Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg (1997) 1.29

Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg (1997) 1.29

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med (1998) 1.29

Pyogenic liver abscess: an improvement in prognosis. Br J Surg (1988) 1.28

Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology (2002) 1.23

Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet (1989) 1.23

Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses. Ann Oncol (2001) 1.22

Heterotopic liver transplantation in end-stage HBsAg-positive cirrhosis. Lancet (1980) 1.21

Biliobiliary fistula. A trap in the surgery of cholelithiasis. Arch Surg (1975) 1.21

Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet (1991) 1.20

Microsatellite instability in European hepatocellular carcinoma. Oncogene (1999) 1.19

Portal diversion for portal hypertension in children. The first ninety patients. Ann Surg (1980) 1.18

Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg (1995) 1.17

Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg (2007) 1.17

Specific transplantation tolerance induced by spontaneously tolerated liver allograft in inbred strains of rats. Transplantation (1980) 1.16

Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma. Histopathology (2001) 1.16

Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology (1996) 1.16

The outcome of steatotic grafts in liver transplantation. Transplant Proc (1991) 1.15

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg (1997) 1.14

De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol (1997) 1.13

The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain (2000) 1.13

Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology (1994) 1.12

Epiploic flap: a new site for islet implantation in man. Horm Metab Res Suppl (1990) 1.12

Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg (2001) 1.12

Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. Transplantation (1990) 1.11

High preoperative serum alanine transferase levels: effect on the risk of liver resection in Child grade A cirrhotic patients. World J Surg (1997) 1.10

Portal diversion for portal hypertension in early childhood. Ann Surg (1976) 1.10

Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. Br J Surg (1992) 1.10

Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 1.08

Hemobilia. N Engl J Med (1973) 1.08

[Rapid diagnosis of cytomegalovirus hepatitis after liver transplantation. Use of monoclonal antibody E13 directed against an early viral antigen]. Ann Pathol (1990) 1.08

Upper gastrointestinal haemorrhage in hepatic cirrhosis: causes and relation to hepatic failure and stress. Lancet (1977) 1.08

Epithelioid hemangioendothelioma of the liver. Diagnostic features and role of liver transplantation. Gastroenterology (1988) 1.07

Acute cholangitis. Multivariate analysis of risk factors. Ann Surg (1989) 1.06

Criteria for hepatic transplantation in cirrhosis. Surg Gynecol Obstet (1980) 1.06

Postoperative liver insufficiency: prevention and management. World J Surg (1983) 1.06

Surgical management of gallstones in cirrhotic patients. Am J Surg (1983) 1.05

Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery (1995) 1.05

Pancreatic debridement in acute necrotizing pancreatitis: an obsolete procedure? Br J Surg (1986) 1.03

Current concepts in cancer: carcinoma of the biliary tract. N Engl J Med (1979) 1.03

Laparoscopic fenestration in polycystic liver disease. Br J Surg (1996) 1.03

Split-liver transplantation for two adult recipients: feasibility and long-term outcomes. Ann Surg (2001) 1.01

Segmental surgery of the liver. Surg Annu (1988) 1.00